search buttonmobile navigation expand button

Need Assistance?

Back to Search Results

Humacyte HAV

A Phase 2 Study for the Evaluation of Safety and Efficacy of Humacyte’s Human Acellular Vessel for Use as a Vascular Prosthesis for Femoro-Popliteal Bypass in Patients with Peripheral Arterial Disease

This study will evaluate how well a new experimental vascular graft (a short piece of tubing through which blood can flow) developed by Humacyte works when surgically implanted into your leg to improve blood flow.  The experimental graft is called the Human Acellular Vessel (HAV).  This study will also evaluate how safe it is to use the HAV in this manner.  We are conducting this study to understand whether the HAV is safe and whether it may offer benefits to patients with disabling PAD who need femoro-popliteal bypass surgery.  

Trial Information
Principal Investigator: Dr. Robert Molnar, MD

Contact: Study Coordinator
Phone (Main): 810-342-3067

IRB Number: 2017-00015 02887859

More Information: